NASDAQ:SBFM | Free Cash Flow | Sunshine Biopharma Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.07M$5,129.00-$2.08M
2025-12-31-$1.62M-$1,039.00-$1.62M
2025-03-31-$1.7M$7,490.00-$1.7M
2024-12-31-$3.41M$102,600.00-$3.51M
2024-03-31-$3.19M$62,937.00-$3.25M
2023-12-31-$2.69M-$382,363.00-$3.07M
2023-03-31-$1.85M
2022-12-31-$2.25M$193,982.00-$2.44M
2022-03-31-$1.3M
2021-12-31-$312,113.00$0.00-$312,113.00-46.79%
2021-03-31-$297,355.00
2020-12-31-$423,672.00$391.00-$424,063.00
2020-03-31-$31,034.00
2019-12-31-$127,839.00
2019-03-31-$233,959.00
2018-12-31-$116,047.00
2018-03-31-$168,455.00
2017-12-31-$209,482.00
2017-03-31-$108,037.00
2016-12-31-$31,194.00
2016-03-31-$81,598.00
2015-12-31-$342,793.00
2015-03-31-$112,996.00
2014-12-31-$247,712.00
2014-03-31-$90,780.00
2013-12-31-$39,747.00
2013-03-31-$339,721.00
2012-12-31-$172,777.00
2012-03-31-$34,757.00
2011-12-31-$117,781.00
2011-06-30-$61,150.00
2011-03-31-$44,330.00
2010-12-31$120,830.00
2010-06-30-$95,825.00
2010-03-31-$1.28M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$5.33M$174,491.00-$5.51M
2024-12-31-$12.52M$1.66M-$14.18M
2023-12-31-$8.78M$82,251.00-$8.86M
2022-12-31-$5.25M$193,982.00-$5.44M
2021-12-31-$1.83M$0.00-$1.83M
2020-12-31-$657,299.00$1,191.00-$658,490.00
2019-12-31-$495,798.00$860.00-$496,658.00
2018-12-31-$512,806.00$18,850.00-$531,656.00
2017-12-31-$543,520.00$3,718.00-$547,238.00
2016-12-31-$314,182.00$3,439.00-$317,621.00
2015-12-31-$867,644.00$4,793.00-$872,437.00
2014-12-31-$538,595.00$0.00-$538,595.00
2013-12-31-$564,398.00
2012-12-31-$393,054.00
2011-12-31-$297,299.00
2010-12-31-$348,325.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.